FEDERALUnknownLow
NANOVIRICIDES, INC.
bd_ccf8d3b28a51ca37 · schema v1 · pii pii-v1
Full breach record for NANOVIRICIDES, INC. →The registrant, a clinical stage biotechnology company, reports in its 10-K Item 1C that as of the filing date, it has not experienced a cybersecurity incident resulting in a material effect on its business strategy, results of operations, or financial condition. The company describes its cybersecurity risk management and governance processes, including reliance on third-party vendors and board oversight.
Tracked as a single-filing incident — the only disclosure on record for this event so far.ConfirmedView incident
Source provenance
- Source URL
- https://www.sec.gov/Archives/edgar/data/1379006/000141057824001650/nnvc-20240630x10k.htm
DisclosureLens renders the full SEC/HHS filing inline below from the originating regulator’s public record (§4.5 fair report privilege).
- Filed at
- Sep 27, 2024
- Raw hash
- 328fd5d6a980a4e12d0f789a646a23ddc7ee90333aa66cbdf38087db4a62eddd
Source filing
AI-assisted summary above. The structured extract on this page was generated from the document below. Inspect the source to verify or correct any field.
Reporting entity
- Name
- Clinical Stage Biotechnology Companynorm: clinical stage biotechnology
Victim entity
- Name
- NANOVIRICIDES, INC.norm: nanoviricides
- SEC CIK
- 1379006
Incident
- Discovered
- —
- Materiality determined
- —
- Notification sent
- —
- Affected individuals
- Not disclosed
- Data types
- —
- Attack vector
- Unknown
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.